Vimarsana
Biggest News Aggregation in the World

Page 13 - Alpine Immune Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpine Immune Sciences Today - Breaking & Trending Today

Baystreet.ca - Vertex Leaps on Purchasing Kidney Research Firm - Vimarsana News

Baystreet.ca - Vertex Leaps on Purchasing Kidney Research Firm

Vertex Pharmaceuticals (NASDAQ:VRTX) will buy Alpine Immune Sciences (NASDAQ:ALPN) for about $4.9 billion in cash, gaining access to the biotech firm’s treatment for an autoimmune disease of the kidney. The deal values each share of Alpine at $65, ...

CarMax, Nike, Paramount and more - Vimarsana News

CarMax, Nike, Paramount and more

Take a look at the companies making headlines in midday trading. CarMax — The used-car retailer fell 13% after reporting fourth-quarter earnings of 32

Top Stock Movers Now: Nike, Constellation Brands, Fastenal, and More - Vimarsana News

Top Stock Movers Now: Nike, Constellation Brands, Fastenal, and More

U.S. equities were mixed at midday Thursday, April 11, 2024 as the latest report on inflation showed wholesale prices rose less than expected in March.

Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday? - Vimarsana News

Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?

Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expec...

Stock market today: Wall Street drifts after another inflation report as worries about rates remain - Vimarsana News

Stock market today: Wall Street drifts after another inflation report as worries about rates remain

U.S. stock indexes are clawing back much of their slide from the day before, when worries that interest rates may stay high for a while rocked Wall Street. The S&P